← Open Payments lookup

KAREN DOUGLAS: Open Payments

NPI 1295988533 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$762 in 27 payments from 7 companies in 2025. Trend: 2023 $887 · 2024 $650 · 2025 $762

Food & beverage: $762
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.10$286
Janssen Pharmaceuticals, Inc7$164
Alkermes, Inc.3$87
E.R. Squibb & Sons, L.L.C.3$82
Luye Pharma (USA) Ltd.1$71
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$51
Axsome Therapeutics, Inc.1$20

Products named: INGREZZA, INVEGA SUSTENNA, COBENFY, ERZOFRI EXTENDED-RELEASE, ARISTADA, CAPLYTA, LYBALVI, Auvelity.

Industry payments across MI — which companies pay providers there.